MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients
G Catalano, A Zaza, C Banella, E Pelosi, G Castelli… - Leukemia, 2023 - nature.com
We characterize the metabolic background in distinct Acute Myeloid Leukemias (AMLs), by
comparing the metabolism of primary AML blasts isolated at diagnosis with that of normal …
comparing the metabolism of primary AML blasts isolated at diagnosis with that of normal …
Cellular and micro-environmental responses influencing the antitumor activity of all-trans retinoic acid in breast cancer
MA Caricasulo, A Zanetti, M Terao, E Garattini… - Cell Communication and …, 2024 - Springer
All-trans retinoic acid (ATRA) is the most relevant and functionally active metabolite of
Vitamin-A. From a therapeutic standpoint, ATRA is the first example of pharmacological …
Vitamin-A. From a therapeutic standpoint, ATRA is the first example of pharmacological …
PER2: a potential molecular marker for hematological malignancies
H Jiang, X Yang, M Mi, X Wei, H Wu, Y Xin… - Molecular Biology …, 2021 - Springer
Circadian rhythm is a periodic change of organism according to the law of external
environment, which is manifested in metabolism, cell proliferation, physiology and behavior …
environment, which is manifested in metabolism, cell proliferation, physiology and behavior …
Gasdermin D deficiency aborts myeloid calcium influx to drive granulopoiesis in lupus nephritis
J Shen, F Li, X Han, D Fu, Y Xu, C Zhu, Z Liang… - Cell Communication and …, 2024 - Springer
Gasdermin D (GSDMD) is emerging as an important player in autoimmune diseases, but its
exact role in lupus nephritis (LN) remains controversial. Here, we identified markedly …
exact role in lupus nephritis (LN) remains controversial. Here, we identified markedly …
Effects of Triheptanoin on Mitochondrial Respiration and Glycolysis in Cultured Fibroblasts from Neutral Lipid Storage Disease Type M (NLSD-M) Patients
Neutral lipid storage disease type M (NLSD-M) is an ultra-rare, autosomal recessive
disorder that causes severe skeletal and cardiac muscle damage and lipid accumulation in …
disorder that causes severe skeletal and cardiac muscle damage and lipid accumulation in …
Role of cardiolipins, mitochondria, and autophagy in the differentiation process activated by all-trans retinoic acid in acute promyelocytic leukemia
M Gianni', L Goracci, A Schlaefli, A Di Veroli… - Cell death & …, 2022 - nature.com
The role played by lipids in the process of granulocytic differentiation activated by all-trans
retinoic acid (ATRA) in Acute-Promyelocytic-Leukemia (APL) blasts is unknown. The …
retinoic acid (ATRA) in Acute-Promyelocytic-Leukemia (APL) blasts is unknown. The …
The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RARα and overcomes ATRA resistance in acute promyelocytic …
M Franza, J Albanesi, B Mancini, R Pennisi… - Biochemical …, 2023 - Elsevier
Acute promyelocytic leukemia (APL) is a hematological disease characterized by the
expression of the oncogenic fusion protein PML-RARα. The current treatment approach for …
expression of the oncogenic fusion protein PML-RARα. The current treatment approach for …
Identification and Absorption–Distribution–Metabolism–Excretion–Toxicity Prediction of Potential MTHFD2 Enzyme Inhibitors from Urtica dioica Ethanolic Leaf Extract
SO Alshammari - Processes, 2024 - mdpi.com
This study aimed to explore the potential of Urtica dioica (U. dioica) ethanolic leaf extract for
cancer treatment by identifying its components, evaluating its effects on cancer cell lines …
cancer treatment by identifying its components, evaluating its effects on cancer cell lines …
Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia
S Novikova, T Tolstova, L Kurbatov… - International Journal of …, 2024 - mdpi.com
Combining new therapeutics with all-trans-retinoic acid (ATRA) could improve the efficiency
of acute myeloid leukemia (AML) treatment. Modeling the process of ATRA-induced …
of acute myeloid leukemia (AML) treatment. Modeling the process of ATRA-induced …
Molecular mechanisms of aberrant neutrophil differentiation in glycogen storage disease type Ib
Glycogen storage disease type Ib (GSD-Ib), characterized by impaired glucose homeostasis,
neutropenia, and neutrophil dysfunction, is caused by a deficiency in glucose-6-phosphate …
neutropenia, and neutrophil dysfunction, is caused by a deficiency in glucose-6-phosphate …